Skip to main content
Veterinary Medicines

GALLIVAC IBD

Authorised
  • Infectious bursal disease virus, strain S706, Live

Product identification

Medicine name:
GALLIVAC IBD
Active substance:
  • Infectious bursal disease virus, strain S706, Live
Target species:
  • Chicken (layer hen)
  • Chicken (broiler)
  • Chicken (for reproduction)
Route of administration:
  • Ocular use
  • Oral use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain S706, Live
    4.00
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for suspension
Withdrawal period by route of administration:
  • Ocular use
    • Chicken (layer hen)
      • Meat and offal
        0
        day
    • Chicken (layer hen)
      • Eggs
        0
        day
    • Chicken (broiler)
      • Meat and offal
        0
        day
    • Chicken (for reproduction)
      • Meat and offal
        0
        day
  • Oral use
    • Chicken (layer hen)
      • Meat and offal
        0
        day
    • Chicken (layer hen)
      • Eggs
        0
        day
    • Chicken (broiler)
      • Meat and offal
        0
        day
    • Chicken (for reproduction)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • ANSES
Authorisation number:
  • FR/V/0111923 5/1992
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."